CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced that Brian M. Culley, Chief Exec…
Author: Business Wire
4D Molecular Therapeutics Raises $75 Million in Series C Financing
EMERYVILLE, Calif.–(BUSINESS WIRE)–4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, announced the closing of its $75 million Series C financing. The round…
Burden of COVID-19 on the Market & Rehabilitation Plan | Global Eyeglasses Market 2020-2024 | High Prevalence of Vision Disorders to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)– #EyeglassesMarket–The Global Eyeglasses Market will grow by $41.98 bn during 2020-2024
Ocular Therapeutix™ to Hold Virtual 2020 Annual Meeting Of Stockholders
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Ocular Therapeutix™ to Present Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
Aldeyra Therapeutics Receives Orphan Medicinal Product Designation from the European Commission for ADX-2191 Retinal Disease Program
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that ADX-2191 has been designated an orphan medicinal product by the European Commission for the treatment of retinal detachment. ADX-2191 is an inve…
IVERIC bio to Announce Zimura® 18 Month Data from the OPH2003 Phase 3 Clinical Trial in Geographic Atrophy Secondary to Age-Related Macular Degeneration and Host Conference Call on Monday, June 15, 2020
NEW YORK–(BUSINESS WIRE)–IVERIC announced that it will report 18 month data from the Zimura® Phase 3 clinical trial in geographic atrophy secondary to AMD on June 15, 2020.
COVID-19 Impact and Recovery Analysis- Optical Coherence Tomography for Ophthalmology Market 2020-2024 | Increasing Incidences of Ocular Diseases to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOpticalCoherenceTomographyforOphthalmologyMarket–The Global Optical Coherence Tomography for Ophthalmology Market will grow by USD 302.3 mn during 2020-2024
Noveome Biotherapeutics Announces Positive Data for Phase 2 Clinical Trial of ST266 in Patients with Persistent Corneal Epithelial Defects
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announced positive…
Aura Biosciences Presents Updated AU-011 Clinical Data at ARVO 2020
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical company developing a novel class of tumor targeted therapies for initial application in primary tumors such as choroidal melanoma, today announced the virtual prese…
MJH Life Sciences™ Launches Medical World News®
CRANBURY, N.J.–(BUSINESS WIRE)– #COVID19–MJH Life Sciences Launches a 24-Hour News Channel for Healthcare Professionals, by Healthcare Professionals.
Insights on the Retinal Surgery Devices Market to 2027 – Featuring Geuder, Insight Instruments & IRIDEX Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Surgery Devices – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis and the looming economic recession, the Retinal Surgery Devices marke…
Aerie Pharmaceuticals Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Global Retinal Surgery Devices Market by Device, Application and Region – Forecast to 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Forecast to 2026” company profile has been added to ResearchAndMarkets.com’s offering. The global retinal sur…
Ocular Therapeutix™ to Present at the 2020 Raymond James Human Health Innovation Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today an…
Kala Pharmaceuticals Announces Virtual-Only Format for 2020 Annual Meeting of Stockholders
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that its 2020 Annual M…
$4.8 Billion Worldwide Ocular Implants Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Implants – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis and the looming economic recession, the Ocular Implants market worldwide will…
Insights on the Soft Contact Lens Global Market to 2027 – Players Include Menicon, Novartis & Sensimed Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Soft Contact Lens – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis and the looming economic recession, the Soft Contact Lens market worldwide …
Glaukos Announces Presentation Cancellation at the William Blair 40th Annual Growth Stock Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Leading BioSciences Teams with Donnelley Financial Solutions to Create Innovative Study Tool for Clinical Trial Monitoring During COVID-19 Pandemic
SAN FRANCISCO–(BUSINESS WIRE)–Donnelley Financial Solutions (NYSE: DFIN), a leading risk and compliance company, today announced that Leading BioSciences, Inc. (LBS), a drug development company focused on improving human health through therapeutic pr…